Literature DB >> 8952517

Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma.

K Ashida1, H Nakatsukasa, T Higashi, S Ohguchi, N Hino, K Nouso, Y Urabe, K Yoshida, N Kinugasa, T Tsuji.   

Abstract

To examine the possible involvement of gelatinase B in human hepatocellular carcinoma (HCC), cellular localization of transcripts and protein of gelatinase B were studied by using in situ hybridization and immunohistochemistry. Transcripts for gelatinase B were observed in tumor cells in 22 cases of 27 HCCs and also in dysplastic nodules. However, there was no significant difference in the expression among histological grades of HCC. The expression was mostly homogeneous, but the intensity varied with the nodules. Of 13 cases with capsular invasion, 12 expressed gelatinase B, whereas 10 of 14 without capsular invasion did (P < 0.05). Gelatinase B transcripts were commonly observed in the sinusoidal cells of the hepatic lobules, in mesenchymal cells both in fibrous capsules and around the necrosis, and also in some undefined cells of the portal tracts of noncancerous liver. Localization of gelatinase B protein was mostly similar to but sometimes different from that of the transcripts in cancer nodules. In conclusion, the expression of gelatinase B appears to be an important characteristic of malignant transformation of hepatocytes. The findings suggest that gelatinase B synthesized by cancer cells plays an important role in the growth and invasion of HCC by degrading surrounding extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952517      PMCID: PMC1865362     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

Authors:  G Murphy; M I Cockett; R V Ward; A J Docherty
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Mechanism of fibrous capsule formation surrounding hepatocellular carcinoma. Immunohistochemical study.

Authors:  T Torimura; T Ueno; S Inuzuka; M Tanaka; H Abe; K Tanikawa
Journal:  Arch Pathol Lab Med       Date:  1991-04       Impact factor: 5.534

3.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.

Authors:  M J Arthur; S L Friedman; F J Roll; D M Bissell
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen.

Authors:  A R Mackay; J L Hartzler; M D Pelina; U P Thorgeirsson
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

5.  Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

Authors:  Y Okada; H Tsuchiya; H Shimizu; K Tomita; I Nakanishi; H Sato; M Seiki; K Yamashita; T Hayakawa
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

6.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

Authors:  S M Wilhelm; I E Collier; B L Marmer; A Z Eisen; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

7.  Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens.

Authors:  W F Grigioni; S Garbisa; A D'Errico; P Baccarini; W G Stetler-Stevenson; L A Liotta; A M Mancini
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

8.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; Y Gonoji; K Naka; K Tomita; I Nakanishi; K Iwata; K Yamashita; T Hayakawa
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

9.  Human 92- and 72-kilodalton type IV collagenases are elastases.

Authors:  R M Senior; G L Griffin; C J Fliszar; S D Shapiro; G I Goldberg; H G Welgus
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

10.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.

Authors:  C Pyke; E Ralfkiaer; P Huhtala; T Hurskainen; K Danø; K Tryggvason
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

View more
  9 in total

1.  Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Authors:  S Mc Donnell; V Chaudhry; J Mansilla-Soto; Z S Zeng; W P Shu; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Tumorigenic potential of extracellular matrix metalloproteinase inducer.

Authors:  S Zucker; M Hymowitz; E E Rollo; R Mann; C E Conner; J Cao; H D Foda; D C Tompkins; B P Toole
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 3.  Matrix metalloproteinases: changing roles in tumor progression and metastasis.

Authors:  Laurie A Shuman Moss; Sandra Jensen-Taubman; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2012-10-12       Impact factor: 4.307

4.  DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.

Authors:  Xiaoling Zhou; Drazen B Zimonjic; Sang-Won Park; Xu-Yu Yang; Marian E Durkin; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

5.  Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen.

Authors:  Yuan-Ping Han; Ling Zhou; Jiaohong Wang; Shigang Xiong; Warren L Garner; Samuel W French; Hidekazu Tsukamoto
Journal:  J Biol Chem       Date:  2003-11-14       Impact factor: 5.157

6.  Matrix metalloproteinases are important for follicular development in normal and miniature pigs.

Authors:  Sang Hwan Kim; Cher Won Kang; Kwan Sik Min; Jong Taek Yoon
Journal:  Biotechnol Lett       Date:  2014-02-22       Impact factor: 2.461

7.  Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma.

Authors:  Wei Sun; Yongchao Zhang; Bozhi Liu; Youjia Duan; Wei Li; Jinglong Chen
Journal:  Can J Gastroenterol Hepatol       Date:  2021-04-28

8.  Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).

Authors:  Isao Okazaki; Takuji Noro; Nobuhiro Tsutsui; Eigoro Yamanouchi; Hajime Kuroda; Masayuki Nakano; Hiroaki Yokomori; Yutaka Inagaki
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

9.  Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages.

Authors:  Bénédicte Delire; Patrick Henriet; Pascale Lemoine; Isabelle A Leclercq; Peter Stärkel
Journal:  Cancer Sci       Date:  2018-06-09       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.